Table 1 Clinical trials of CC-90009
From: Key regulators of sensitivity to immunomodulatory drugs in cancer treatment
Phase | Conditions | Interventions | NCT ID | |
|---|---|---|---|---|
1 | Healthy Volunteer | CC-90009 Radiation: [14Â C] | NCT04297124 | |
1 | AML, MDS | CC-90009 | NCT02848001 | |
1, 2 | AML | CC-90009, Venetoclax, Azacitidine, Gilteritinib | NCT04336982 | |